Participated · Seed · Feb 2026

ORamaVR builds CMXR, an extended-reality platform that blends artificial intelligence, medical knowledge, robotic digital twins, and real-time analytics to address training, planning, navigation, rehabilitation, and therapy in healthcare. The software runs on standard hardware and is marketed to manufacturers of medical devices and surgical robots as well as nursing schools and medical training centers. Independent clinical studies cited by the company show a 32% improvement in medical skills and an 80% reduction in errors when using the platform. ORamaVR’s neurosymbolic AI-based MAGES-SUITE has already been adopted by institutions worldwide, giving the firm early commercial traction. With the newly raised capital, the company plans to scale product development, fulfill existing commercial contracts with leading hardware manufacturers, and expand global sales. The firm also strengthened its leadership team by appointing Jan Grund Pedersen as Chief Business Officer. No revenue figures were disclosed, but the company indicates that multiple commercial agreements are in place.